Although MT showed increased expression in various human tumors of the breast, kidney, lung, nasopharynx, ovary, salivary gland, testes, thyroid and urinary bladder [26], [27], which was downregulated in certain tumors such as hepatocellular carcinoma (HCC), prostate and colorectal cancer [28]. This evidence concerns the gene MCAT and colorectal cancer.